ClinicalTrials.Veeva

Menu

Childhood Trauma, Exercise, and Cognition (CTEC)

The University of Texas System (UT) logo

The University of Texas System (UT)

Status

Enrolling

Conditions

Adverse Childhood Experiences

Treatments

Behavioral: Placebo - Light Intensity Exercise (one day)
Behavioral: Moderate Intensity Exercise (9 wks)
Other: Day 78 Assessments
Behavioral: Moderate Intensity Exercise (one day)
Other: Day 1 Assessments
Other: Day 57 Assessments
Other: Symptom Measures and Neuropsychological Tests
Other: Day 36 Assessments

Study type

Interventional

Funder types

Other

Identifiers

NCT05972265
STUDY00004558

Details and patient eligibility

About

This study aims to identify and compare the effects of acute and chronic exercise interventions on cognition in middle-aged adults with cognitive complaints and a history of abuse or neglect in childhood. Each participant will be enrolled in the study for up to 78 days, in five parts following verification that the participant meets criteria to be included in the study: 1) initial assessment; 2) first acute exercise condition in lab, symptom measures, and neuropsychological testing; 3) second acute exercise condition in lab, symptom measures, and neuropsychological testing; and 4) 9-week exercise intervention or activity as usual outside of lab, with interview, symptom measures, and neuropsychological testing at three-week intervals.

Enrollment

34 estimated patients

Sex

All

Ages

40 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • between 40 and 60 years of age
  • history of child abuse or neglect
  • have a complaint about memory, attention, or executive function
  • native or fluent English speaker
  • normal or corrected to normal vision and hearing
  • medically healthy

Exclusion criteria

  • Score indicating a history of moderate-intensity activity, hard-intensity activity, or very-hard intensity activity on the Stanford Brief Activity Survey
  • current excessive alcohol or other substance use
  • eating disorder, bipolar disorder, schizophrenia spectrum disorders, or those judged to be an immediate suicide risk based on having an active plan with intent
  • autism spectrum disorder, attention-deficit/hyperactivity disorder (ADHD), or other neurodevelopmental disorder
  • neurocognitive disorder, or illnesses or history of neurological events known to cause neurocognitive disorders (e.g., traumatic brain injury, status epilepticus, stroke)
  • reported chest pain or dizziness during exercise; any endorsed and not controlled medical condition that could make exercise contraindicated, including hypertension; heart disease; heart failure; hear rhythm disorders; heart valve disease; metabolic conditions; chronic obstructive pulmonary disease; pulmonary hypertension; cystic fibrosis; asthma; and bone, joint, or soft tissue problems
  • pregnancy, major medical disorders such as cancer, or any other condition believed to put a participant at risk

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

34 participants in 4 patient groups

Acute Exercise Moderate first
Experimental group
Description:
Day 1 Assessments, Day 8 Moderate Intensity Exercise (followed by symptom measures and neuropsychological tests), Day 15 Light Intensity Exercise (symptom measures and neuropsychological tests)
Treatment:
Other: Symptom Measures and Neuropsychological Tests
Behavioral: Placebo - Light Intensity Exercise (one day)
Behavioral: Moderate Intensity Exercise (one day)
Other: Day 1 Assessments
Acute Exercise Light first
Active Comparator group
Description:
Control Day 1 Assessments (symptom measures, neuropsychological tests, and cognitive complaints interview), Day 8 Light Intensity Exercise (followed by symptom measures and neuropsychological tests), Day 15 Moderate Intensity Exercise (symptom measures and neuropsychological tests)
Treatment:
Other: Symptom Measures and Neuropsychological Tests
Behavioral: Placebo - Light Intensity Exercise (one day)
Behavioral: Moderate Intensity Exercise (one day)
Other: Day 1 Assessments
Chronic Exercise Moderate
Experimental group
Description:
9-weeks Moderate Intensity Exercise Day 36 (at 3 weeks) Assessments Day 57 (at 6 weeks) Assessments Day 78 (at 9 weeks) Assessments
Treatment:
Other: Day 36 Assessments
Behavioral: Moderate Intensity Exercise (9 wks)
Other: Day 78 Assessments
Other: Day 57 Assessments
Activity as Usual
No Intervention group
Description:
9-week activity as usual Day 36 (at 3 weeks) Assessments Day 57 (at 6 weeks) Assessments Day 78 (at 9 weeks) Assessments

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems